CD56 in the Immune System: More Than a Marker for Cytotoxicity?

by Heleen H. Van Acker, Anna Capsomidis, Evelien L. Smits, Evelien L. Smits, Evelien L. Smits, Viggo F. Van Tendeloo
Published 2017-07-01

Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion

by Heleen H. Van Acker, Sébastien Anguille, Sébastien Anguille, Hans De Reu, Zwi N. Berneman, Zwi N. Berneman, Zwi N. Berneman, Evelien L. Smits, Evelien L. Smits, Evelien L. Smits, Viggo F. Van Tendeloo
Published 2018-04-01

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

by Sévérine de Bruijn, Sébastien Anguille, Joris Verlooy, Evelien L. Smits, Viggo F. van Tendeloo, Maxime de Laere, Koenraad Norga, Zwi N. Berneman, Eva Lion
Published 2019-09-01

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

by Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Johan M. Van den Bergh, Zwi N. Berneman, Eva Lion, Evelien L. Smits, Viggo F. Van Tendeloo
Published 2016-09-01

Correction: Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

by Sébastien Anguille, Eva Lion, Jurjen Tel, I. Jolanda M de Vries, Karen Couderé, Phillip D. Fromm, Viggo F. Van Tendeloo, Evelien L. Smits, Zwi N. Berneman
Published 2014-01-01

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.

by Sébastien Anguille, Heleen H Van Acker, Johan Van den Bergh, Yannick Willemen, Herman Goossens, Viggo F Van Tendeloo, Evelien L Smits, Zwi N Berneman, Eva Lion
Published 2015-01-01

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.

by Sébastien Anguille, Eva Lion, Jurjen Tel, I Jolanda M de Vries, Karen Couderé, Phillip D Fromm, Viggo F Van Tendeloo, Evelien L Smits, Zwi N Berneman
Published 2012-01-01

Correction: Interleukin-15-Induced CD56 Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential.

by Sébastien Anguille, Eva Lion, Jurjen Tel, I. Jolanda M de Vries, Karen Couderé, Phillip D. Fromm, Viggo F. Van Tendeloo, Evelien L. Smits, Zwi N. Berneman
Published 2014-01-01

CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15

by Heleen H. Van Acker, Zoë P. Van Acker, Maarten Versteven, Peter Ponsaerts, Daniela Pende, Zwi N. Berneman, Sébastien Anguille, Viggo F. Van Tendeloo, Evelien L. Smits
Published 2019-07-01

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

by Thomas J. van Ee, Heleen H. Van Acker, Tom G. van Oorschot, Viggo F. Van Tendeloo, Evelien L. Smits, Ghaith Bakdash, Gerty Schreibelt, I. Jolanda M. de Vries
Published 2018-09-01

Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.

by Suzanne E Brooks, Stephanie A Bonney, Cindy Lee, Amy Publicover, Ghazala Khan, Evelien L Smits, Dagmar Sigurdardottir, Matthew Arno, Demin Li, Ken I Mills, Karen Pulford, Alison H Banham, Viggo van Tendeloo, Ghulam J Mufti, Hans-Georg Rammensee, Tim J Elliott, Kim H Orchard, Barbara-ann Guinn
Published 2015-01-01